| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |